NovaBay Pharmaceuticals Inc (NBY)
0.077
0.00 (0.00%)
USD |
NYAM |
Apr 25, 16:00
0.08
0.00 (0.00%)
After-Hours: 07:16
NovaBay Pharmaceuticals Cash from Investing (Quarterly): -0.002M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.002M |
September 30, 2023 | -0.002M |
June 30, 2023 | -0.002M |
March 31, 2023 | -0.013M |
December 31, 2022 | 0.00 |
September 30, 2022 | -0.08M |
June 30, 2022 | -0.008M |
March 31, 2022 | -0.024M |
December 31, 2021 | -12.00M |
September 30, 2021 | -0.017M |
June 30, 2021 | -0.002M |
March 31, 2021 | -0.025M |
December 31, 2020 | -0.021M |
September 30, 2020 | -0.005M |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | -0.005M |
March 31, 2019 | -0.014M |
December 31, 2018 | -0.031M |
September 30, 2018 | -0.008M |
June 30, 2018 | -0.003M |
March 31, 2018 | -0.002M |
December 31, 2017 | -0.016M |
Date | Value |
---|---|
September 30, 2017 | -0.073M |
June 30, 2017 | -0.096M |
March 31, 2017 | -0.059M |
December 31, 2016 | -0.082M |
September 30, 2016 | -0.04M |
June 30, 2016 | -0.022M |
March 31, 2016 | -0.016M |
December 31, 2015 | -0.077M |
September 30, 2015 | -0.024M |
June 30, 2015 | -0.008M |
March 31, 2015 | 0.023M |
December 31, 2014 | 1.265M |
September 30, 2014 | 2.514M |
June 30, 2014 | 1.143M |
March 31, 2014 | -2.324M |
December 31, 2013 | 1.223M |
September 30, 2013 | 0.914M |
June 30, 2013 | -0.044M |
March 31, 2013 | -0.686M |
December 31, 2012 | 0.426M |
September 30, 2012 | 0.994M |
June 30, 2012 | -0.521M |
March 31, 2012 | 0.464M |
December 31, 2011 | -3.535M |
September 30, 2011 | -0.967M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-12.00M
Minimum
Dec 2021
--
Maximum
Sep 2019
-0.6425M
Average
-0.005M
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
Eyenovia Inc | -0.1452M |
Palatin Technologies Inc | 9.462M |
iBio Inc | 0.00 |
Theriva Biologics Inc | -0.056M |
Oragenics Inc | -1.00M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -0.314M |
Cash from Financing (Quarterly) | -0.026M |
Free Cash Flow | -4.15M |
Free Cash Flow Per Share (Quarterly) | -0.0281 |
Free Cash Flow to Equity (Quarterly) | -0.183M |
Free Cash Flow Yield | -1.02K% |